Insider Selling: Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Sells $163,033.20 in Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Jodie Pope Morrison sold 9,845 shares of the company’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total transaction of $163,033.20. Following the sale, the chief executive officer directly owned 343,259 shares in the company, valued at $5,684,369.04. This represents a 2.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Leverage Shares 2X Long FIX Daily ETF Trading Down 11.5%

BATS FIXX opened at $11.27 on Friday. Leverage Shares 2X Long FIX Daily ETF has a 1-year low of $11.27 and a 1-year high of $14.30.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.